Cargando…

Müllerian Adenosarcoma: A Single-Centre Experience of 59 Cases of This Rare Entity

Background and objective Müllerian adenosarcomas (MA) are rare biphasic tumors with benign epithelial and sarcomatous stromal components. There is very limited cohort study data on MA in the South Asian countries and no such study has been attempted in Pakistan. Our aim was to evaluate the clinicopa...

Descripción completa

Detalles Bibliográficos
Autores principales: Rana, Iftikhar Ali, Hassan, Usman, Bashir, Shaarif, Hussain, Mudassar, Shakeel, Mehroosh, Mushtaq, Sajid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969483/
https://www.ncbi.nlm.nih.gov/pubmed/33747657
http://dx.doi.org/10.7759/cureus.13360
_version_ 1783666232091738112
author Rana, Iftikhar Ali
Hassan, Usman
Bashir, Shaarif
Hussain, Mudassar
Shakeel, Mehroosh
Mushtaq, Sajid
author_facet Rana, Iftikhar Ali
Hassan, Usman
Bashir, Shaarif
Hussain, Mudassar
Shakeel, Mehroosh
Mushtaq, Sajid
author_sort Rana, Iftikhar Ali
collection PubMed
description Background and objective Müllerian adenosarcomas (MA) are rare biphasic tumors with benign epithelial and sarcomatous stromal components. There is very limited cohort study data on MA in the South Asian countries and no such study has been attempted in Pakistan. Our aim was to evaluate the clinicopathological characteristics of MA and to review the published literature on the condition. Additionally, we also analyzed the impact of various prognostic factors on the overall survival (OS) of patients with MA. Materials and methods This was a retrospective observational study performed at the Shaukat Khanum Memorial Hospital and Research Centre, Lahore from 2003 to 2020. A total of 59 histologically confirmed cases of MA were included in the study and critically reviewed. Results The mean age of the patients was 54 ±16 years, and the most common tumor location was the uterine corpus (48, 81.4%), followed by the cervix (eight, 13.6%), ovary (two, 3.4%), and vagina (one, 1.7%). Sarcomatous overgrowth (SO) was seen in 22 (37.3%) patients, and high-grade cytology was observed in 18 (30.5%) patients. Furthermore, lymphovascular invasion (LVI) was present in six (10.2%) patients, and myometrial invasion was noted in 25 (42.4%) patients. The follow-up details of 29 patients were available, and death was recorded in 13 (44.8%) patients with a median OS of three years. Conclusion MA is a rare and diagnostically challenging entity due to its wide differential diagnosis. It is essential to take note of different morphological features such as SO, cytological features, LVI, and heterologous differentiation because of their significant prognostic impact.
format Online
Article
Text
id pubmed-7969483
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-79694832021-03-19 Müllerian Adenosarcoma: A Single-Centre Experience of 59 Cases of This Rare Entity Rana, Iftikhar Ali Hassan, Usman Bashir, Shaarif Hussain, Mudassar Shakeel, Mehroosh Mushtaq, Sajid Cureus Obstetrics/Gynecology Background and objective Müllerian adenosarcomas (MA) are rare biphasic tumors with benign epithelial and sarcomatous stromal components. There is very limited cohort study data on MA in the South Asian countries and no such study has been attempted in Pakistan. Our aim was to evaluate the clinicopathological characteristics of MA and to review the published literature on the condition. Additionally, we also analyzed the impact of various prognostic factors on the overall survival (OS) of patients with MA. Materials and methods This was a retrospective observational study performed at the Shaukat Khanum Memorial Hospital and Research Centre, Lahore from 2003 to 2020. A total of 59 histologically confirmed cases of MA were included in the study and critically reviewed. Results The mean age of the patients was 54 ±16 years, and the most common tumor location was the uterine corpus (48, 81.4%), followed by the cervix (eight, 13.6%), ovary (two, 3.4%), and vagina (one, 1.7%). Sarcomatous overgrowth (SO) was seen in 22 (37.3%) patients, and high-grade cytology was observed in 18 (30.5%) patients. Furthermore, lymphovascular invasion (LVI) was present in six (10.2%) patients, and myometrial invasion was noted in 25 (42.4%) patients. The follow-up details of 29 patients were available, and death was recorded in 13 (44.8%) patients with a median OS of three years. Conclusion MA is a rare and diagnostically challenging entity due to its wide differential diagnosis. It is essential to take note of different morphological features such as SO, cytological features, LVI, and heterologous differentiation because of their significant prognostic impact. Cureus 2021-02-15 /pmc/articles/PMC7969483/ /pubmed/33747657 http://dx.doi.org/10.7759/cureus.13360 Text en Copyright © 2021, Rana et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Obstetrics/Gynecology
Rana, Iftikhar Ali
Hassan, Usman
Bashir, Shaarif
Hussain, Mudassar
Shakeel, Mehroosh
Mushtaq, Sajid
Müllerian Adenosarcoma: A Single-Centre Experience of 59 Cases of This Rare Entity
title Müllerian Adenosarcoma: A Single-Centre Experience of 59 Cases of This Rare Entity
title_full Müllerian Adenosarcoma: A Single-Centre Experience of 59 Cases of This Rare Entity
title_fullStr Müllerian Adenosarcoma: A Single-Centre Experience of 59 Cases of This Rare Entity
title_full_unstemmed Müllerian Adenosarcoma: A Single-Centre Experience of 59 Cases of This Rare Entity
title_short Müllerian Adenosarcoma: A Single-Centre Experience of 59 Cases of This Rare Entity
title_sort müllerian adenosarcoma: a single-centre experience of 59 cases of this rare entity
topic Obstetrics/Gynecology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969483/
https://www.ncbi.nlm.nih.gov/pubmed/33747657
http://dx.doi.org/10.7759/cureus.13360
work_keys_str_mv AT ranaiftikharali mullerianadenosarcomaasinglecentreexperienceof59casesofthisrareentity
AT hassanusman mullerianadenosarcomaasinglecentreexperienceof59casesofthisrareentity
AT bashirshaarif mullerianadenosarcomaasinglecentreexperienceof59casesofthisrareentity
AT hussainmudassar mullerianadenosarcomaasinglecentreexperienceof59casesofthisrareentity
AT shakeelmehroosh mullerianadenosarcomaasinglecentreexperienceof59casesofthisrareentity
AT mushtaqsajid mullerianadenosarcomaasinglecentreexperienceof59casesofthisrareentity